Pharmaceutical Technology

AUGUST 1, 2023

Vepdegestrant was awarded the Innovation Passport designation for treating advanced or metastatic breast cancer.

52

52

Pharmatutor

DECEMBER 27, 2021

AROMATASE INHIBITORS IN BREAST CANCER. Read more about AROMATASE INHIBITORS IN BREAST CANCER Log in or register to post comments Read more about AROMATASE INHIBITORS IN BREAST CANCER Log in or register to post comments About Authors. MANISHA KOTADIYA*, JAYDEEP SAVALIYA. DOWNLOAD AS PDF.

Pharma 52

Pharma 52

World of DTC Marketing

DECEMBER 13, 2021

OPENING: American cancer patients spent more than $21 billion on their care in 2019. As cancer survival rates rise, so do the price tags of life-saving treatments. Some cancer patients may face out-of-pocket costs of nearly $12,000 a year for one drug. What makes cancer such a financial killer? ScienceNews.com.

Food and Drug Administration 55

Food and Drug Administration Food Medical Insurance 55

European Pharmaceutical Review

AUGUST 24, 2022

ANTIBODY-DRUG conjugates (ADCs) are therapeutic molecules designed as highly targeted medicines with the promise of changing the way we treat cancer and other diseases. cancer agent or disease-relevant toxin. 2 The role of the antibody is to deliver the payload to a specific site such as a cancer cell.

Engineering 81

Engineering Side effects Marketing Patients 81

Medico Reach

AUGUST 30, 2022

The campaign went viral on Twitter when it took to answering questions about breast cancer. Anyone could post a query using the tag YESMAMM, and they would get an immediate response. Considering the estimated number of breast cancer cases stands at 287,850 in 2022 , the ‘YESMAMM’ campaign is relevant even today.

Healthcare 52

Healthcare Healthcare Marketing Medical 52